15th Annual Meeting of The Photomedicine
Society
Thursday, March 2, 2006
Nob Hill B, San
Francisco Marriott, San Francisco, CA, USA
7:30-8:00 Registration/refreshments
8:00-8:10 OPENING REMARKS: Ponciano D. Cruz, Jr., MD
ORAL SESSION I - Basic Science Session (Nob Hill B): Moderated
by Sewon Kang, MD
PHOTOCARCINOGENESIS
8:10 – 8:20 *Abstract 1
Implications of the folate pathway and MTHFR polymorphism for
the risk of squamous cell
carcinoma in renal transplant patients. Laing ME, Dicker
P, Moloney FJ, Shields DC,
Conlon P, Murphy GM. Beaumont Hospital and Royal College
of Surgeons, Dublin, Ireland.
8:20 – 8:30 Abstract 2
Risk assessment of topical calcineurin inhibitors. Yarosh
DB, Pena AY, Nay SL, Canning
MT. AGI Dermatics, Freeport, NY, USA.
8:30 – 8:40 Abstract 3
Fate of UVB-induced p53 mutations in SKH-hr1 mourse skin
after discontinuation of
irradiation: relationship to skin cancer development.
Pacifico A, Leone G, Picardo M,
Ananthaswamy HN. S. Gallicano Institute, Rome, Italy
and M.D. Anderson Cancer Center,
Houston, TX, USA.
8:40-8:45 Q&A
PHOTOBIOLOGY
8:45 – 8:55 Abstract 4
Role of recombination repair in the cellular response
to ultraviolet light. Rünger TM, Dunn J,
Potter M, Rees A. Boston University, Boston, MA,
USA.
8:55-9:30 SPECIAL TOPICS:
"
New developments in broad spectrum UV protection". Uli
Osterwalder, Ph.D., CIBA
Specialty Chemicals, Basel, Switzerland.
9:30-9:35 Q&A
9:35– 9:50 BREAK FOR COFFEE
9:50 – 10:00 Abstract 5
Intrinsic collagen fluorescence can tell us about
ground - and excited state processes. Menter
JM. Morehouse School of Medicine, Atlanta,
GA, USA.
10:00 –10:10 Abstract 6
Protection against ultraviolet-induced matrix metalloproteinase
1 (MMP1) upregulation: a
comparison of sunscreen versus sunscreen plus antioxidants. Miller
JD, Hanneman K,
Alikhan A, Khouri J, Matsui M, Maes D, Scull H, Cooper KD, Baron
ED. Case Western
Reserve University, Cleveland, OH, USA
10:10 – 10:20 Abstract 7
Photodegradation of folic acid during extracorporeal photochemotherapy.
Der-Petrossian M,
Födinger M, Knobler R, Hoenigsmann H, Trautinger F. Medical
University of Vienna,
Vienna, Austria.
10:20-10:30 Q&A
10:30-11:30 GUEST SPEAKER: John Hawk, MD "The
Idiopathic Photodermatoses Are Not Really
Idiopathic?” Introduction by Warwick L. Morison, MD
11:30-1:00 Lunch
ORAL SESSION II - Clinical Session (Nob Hill B): Moderated
by Michael Zanolli, MD and
Heidi Jacobe, MD
PSORIASIS
1:00-1:10 Abstract 8
Treatment of palmoplantar psoriasis: monochromatic
excimer light (308 nm) versus cream
PUVA. Korpusik D, Mahnke N, Stege H, Ruzicka T,
Neumann NJ. Heinrich-Heine
University, Duesseldorf, Germany.
1:10-1:20 *Abstract 9
A prospective randomised double blind trial of
the efficacy of narrowband UVB (TL01)
phototherapy and psoralen photochemotherapy (PUVA)
in the treatment of chronic plaque
psoriasis (CPP). Yones SS, Palmer RA, Garibaldinos
T, Hawk JLM. King's College St.
Thomas Hospital, London, United Kingdom.
1:20-1:30 *Abstract 13
Improvement in quality of life in psoriasis is
correlated with the improvement in psoriasis
area
and severity index that occurs with phototherapy.
Yones SS, Palmer RA, Hawk JLM. King's
College St. Thomas Hospital, London, United
Kingdom.
1:30-1:40 Abstract 11
Effective treatment of scalp psoriasis using
the excimer (308 nm) laser. Morison WL,
Atkinson DF, Werthman L. Johns Hopkins at
Greenspring, Baltmore, MD, USA.
1:40-1:45 Q&A
MYCOSIS FUNGOIDES
1:45-1:55 Abstract 12
Mycosis fungoides: epidemiologic study of
17 cases and evaluation of PUVA (psoralen
with
ultraviolet radiation A) photochemotherapy
response. Duarte I, Buense R, Aoki
S. Santa
Casa de São Paulo Medical School, São Paulo,
Brazil.
VITILIGO
1:55-2:05 *Abstract 10
A prospective randomised double blind trial of the efficacy of
narrowband UVB (TL01)
phototherapy and psoralen photochemotherapy (PUVA) in the treatment
of vitiligo. Yones SS,
Palmer RA, Garibaldinos T, Hawk JLM. King's College St. Thomas
Hospital, London, United
Kingdom.
2:05-2:10 Q&A
PHOTOSENSITIVITY DISORDERS
2:10-2:20 *Abstract 14
Rothmund-Thompson syndrome associated with subacute cutaneous lupus
erythematosus and
erythema multiforme. Barry J, Laing M, Murphy G. Beaumont
Hospital, Dublin, Ireland.
2:20-2:30 Abstract 15
Erythropoietic protoporphyria: predictive value of cordblood
analysis. Hanneken S, Kuerten
V, Gardlo K, Lehmann P, Neumann NJ. Heinrich-Heine University,
Duesseldorf, Germany.
2:30-2:40 Abstract 16
Porphyria cutanea tarda in patients with end stage renal
disease. Rosen CF. Toronto
Western Hospital, Toronto, Ontario, Canada.
2:40-2:45 Q&A
2:45-3:15 SPECIAL TOPICS
Photodynamic Therapy: Moderated by Iltefat H. Hamzavi,
M.D.
Panel Members: Rolf Szeimies, M.D.
Sarah Weitzul, M.D.
3:15-3:30 BREAK FOR COFFEE
PHOTOTHERAPY/PDT
3:30-3:40 Abstract 17
Phase 1 clinical trial using topical silicon phthalocyanine-photodynamic
therapy for the
treatment of malignant and pre-malignant
skin conditions: an update. Miller JD, Scull
HM,
Oleinick N, Hsia A, Cooper KD, Baron ED.
Case Western Reserve University/University
Hospitals, Cleveland, OH, USA.
3:40-3:50 Abstract 18
Grotesque lupus pernio. Successful result
after multiple treatment modes. Wishart
JM.
Greenlane Hospital, Auckland, New Zealand.
PHOTOIMMUNOLOGY
3:50-4:00 Abstract 19
Narrow-band UVB radiation has the suppressive
effects on delayed-type hypersensitivity
and
contact hypersensitivity. Shintani
Y, Morita A. Nagoya City University,
Nagoya,
Japan.
4:00-4:05 Q&A
TECHNICAL ASPECTS
4:05-4:15 Abstract 20
Colorimetric monitoring of post inflammatory pigmentation: preliminary
observations.
Robaee AA, Khayat H, Zhao J, Zeng H, McLean DI, Lui H. University
of British Columbia
and British Columbia Cancer Agency, Vancouver, British Columbia.
4:15-4:25 *Abstract 21
The relationship between skin type, minimal erythema dose and episodes
of erythema during
narrowband ultraviolet-B therapy in 352 patients. Palmer RA,
Aquilina S, Milligan PJ,
Walker SL, Young AR, Hawk JL. St. John's Institute of Dermatology
and Statistics in School
of Life and Health Sciences, King's College, London, United Kingdom.
4:25-4:35 Abstract 22
Development of a hand-held apparatus to measure minimal erythema
dose for narrow-band
UVB using a new flat-type fluorescent lamp. Morita A, Shintani
Y, Kobayashi K, Yoshida H,
Minamoto M. Nagoya City University School of Medicine, Nagoya,
Japan.
4:35:4:40 Q&A
* Contenders for “Best Presentation by Resident/Fellow”.
5:30-8:00 COCKTAIL/RECEPTION: In conjunction with the American
Contact Dermatitis Society
|
